The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 16, 2014
Filed:
Feb. 08, 2011
Jonathan Robert Coppeta, Windham, NH (US);
Kenneth N. Horne, San Francisco, CA (US);
John T. Santini, Jr., North Chelmsford, MA (US);
John A. Scholl, San Ramon, CA (US);
Gregory J. R. Spooner, San Francisco, CA (US);
Cynthia L. Stevenson, Mountain View, CA (US);
Naveed Shams, Danville, CA (US);
Andrew Poutiatine, Mill Valley, CA (US);
Jonathan Robert Coppeta, Windham, NH (US);
Kenneth N. Horne, San Francisco, CA (US);
John T. Santini, Jr., North Chelmsford, MA (US);
John A. Scholl, San Ramon, CA (US);
Gregory J. R. Spooner, San Francisco, CA (US);
Cynthia L. Stevenson, Mountain View, CA (US);
Naveed Shams, Danville, CA (US);
Andrew Poutiatine, Mill Valley, CA (US);
On Demand Therapeutics, Inc., Tyngsboro, MA (US);
Abstract
An implantable drug delivery device that uses multiple reservoir elements to contain and release doses of active pharmaceutical ingredients. The device includes a first shell element, which has a first enclosed cavity volume and forms a low-permeability barrier. The first shell element is configured to absorb light irradiation from a laser source, the laser irradiation causing a breach in the first shell element. A first active pharmaceutical ingredient is contained in the first enclosed cavity volume and is released when the first shell element is breached. The device also includes a second shell element, which has a second enclosed cavity volume and also forms a low-permeability barrier. A second active pharmaceutical ingredient is contained in the second enclosed cavity volume. The device also includes an envelope element containing the first and second shell elements.